Astrotech vs YD Bio
Astrotech is the larger business, with $913,000 of revenue in fiscal 2026 against $596,817 for YD Bio (1.5 times as much). YD Bio grew faster (16.9% against -8.7%). YD Bio kept more of each dollar of sales as profit: a net margin of -1392.6% against -1580.2%.
| Latest fiscal year | AstrotechASTC, 2026 | YD BioYDES, 2025 |
|---|---|---|
| Revenue | $913,000 | $596,817 |
| Revenue growth | -8.7% | 16.9% |
| Net income | −$14.4m | −$8.3m |
| Operating margin | -1548.5% | -883.3% |
| Net margin | -1580.2% | -1392.6% |
| Return on equity | -75.4% | — |
| Free cash flow | −$14.3m | −$8.0m |
| Cash | $8.4m | $6.0m |
| Total debt | $0 | $6,764 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $9.7m | $446m |
| Price vs our value range | — | — |
| Moat score | 9 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 3 buys, 0 sales |